These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 12955294)

  • 1. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
    Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB
    Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
    Murphy GM; Hollander SB; Rodrigues HE; Kremer C; Schatzberg AF
    Arch Gen Psychiatry; 2004 Nov; 61(11):1163-9. PubMed ID: 15520364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
    Umene-Nakano W; Yoshimura R; Ueda N; Suzuki A; Ikenouchi-Sugita A; Hori H; Otani K; Nakamura J
    J Psychopharmacol; 2010 Dec; 24(12):1764-71. PubMed ID: 19825907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between serotonin transporter gene promoter-region polymorphism and 4- and 12-week treatment response to sertraline in posttraumatic stress disorder.
    Mushtaq D; Ali A; Margoob MA; Murtaza I; Andrade C
    J Affect Disord; 2012 Feb; 136(3):955-62. PubMed ID: 21962566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression.
    Schneider LS; Nelson JC; Clary CM; Newhouse P; Krishnan KR; Shiovitz T; Weihs K;
    Am J Psychiatry; 2003 Jul; 160(7):1277-85. PubMed ID: 12832242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism.
    Kato M; Ikenaga Y; Wakeno M; Okugawa G; Nobuhara K; Fukuda T; Fukuda K; Azuma J; Kinoshita T
    Int Clin Psychopharmacol; 2005 May; 20(3):151-6. PubMed ID: 15812265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
    Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between functional polymorphisms in serotonin transporter gene (SLC6A4) and escitalopram treatment response in depressive patients in a South Indian population.
    Mandal T; Bairy LK; Sharma PSVN
    Eur J Clin Pharmacol; 2020 Jun; 76(6):807-814. PubMed ID: 32253447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HTTLPR polymorphism of the serotonin transporter gene predicts non-remission in major depression patients treated with citalopram in a 12-weeks follow up study.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Clin Psychopharmacol; 2003 Dec; 23(6):563-7. PubMed ID: 14624186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and structural equation model of sertraline treatment response in Japanese patients with major depressive disorder.
    Nishioka G; Yashima H; Kiuchi Y; Nakamura S; Oyamada H; Ishii M; Kudo I
    Hum Psychopharmacol; 2013 Nov; 28(6):576-85. PubMed ID: 24519691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
    Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
    JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serotonin transporter and receptor gene polymorphisms in treatment response to selective serotonin reuptake inhibitors in major depressive disorder.
    Ramesh V; Venkatesan V; Ramasamy B
    Hum Psychopharmacol; 2022 Jul; 37(4):e2830. PubMed ID: 34994008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
    J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to sertraline is influenced by GNβ3 gene G-350A variant in patients with major depressive disorder.
    Firouzabadi D; Firouzabadi N; Kalani K; Zomorrodian K; Tehrani ES
    Eur J Clin Pharmacol; 2019 Feb; 75(2):189-194. PubMed ID: 30324302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities.
    Ng CH; Easteal S; Tan S; Schweitzer I; Ho BK; Aziz S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jul; 30(5):953-7. PubMed ID: 16580768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment.
    Perlis RH; Mischoulon D; Smoller JW; Wan YJ; Lamon-Fava S; Lin KM; Rosenbaum JF; Fava M
    Biol Psychiatry; 2003 Nov; 54(9):879-83. PubMed ID: 14573314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
    Myung W; Lim SW; Kim S; Kim H; Chung JW; Seo MY; Kim JW; Carroll BJ; Kim DK
    Psychopharmacology (Berl); 2013 Jan; 225(2):283-90. PubMed ID: 22885912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression.
    Neumeister A; Konstantinidis A; Stastny J; Schwarz MJ; Vitouch O; Willeit M; Praschak-Rieder N; Zach J; de Zwaan M; Bondy B; Ackenheil M; Kasper S
    Arch Gen Psychiatry; 2002 Jul; 59(7):613-20. PubMed ID: 12090814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of serotonin transporter promoter region polymorphisms on hippocampal volumes in late-life depression.
    Taylor WD; Steffens DC; Payne ME; MacFall JR; Marchuk DA; Svenson IK; Krishnan KR
    Arch Gen Psychiatry; 2005 May; 62(5):537-44. PubMed ID: 15867107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.